Pharmafile Logo
Pharmafocus logo
Advanced Search
facilities_lg06

Court fines Dr Reddy’s for improperly packaging products

January 22, 2018
Sales and Marketing Dr Reddy's, biotech, drugs, pharma, pharmaceutical

On 18 December 2017, the District of New Jersey filed a complaint against Dr. Reddy’s Laboratories for failing to comply …

News
epilim

20,000 left disabled in UK due to sodium valproate use during pregnancy

January 22, 2018
Medical Communications, Sales and Marketing Epilim, Sanofi, Sodium valproate, UK, pharma

Liberal Democrat MP Norman Lamb has drawn attention to what he has called an “extraordinary scandal” in which an estimated …

News
sanofi_new_paris_hq

Sanofi finally seals big deal with $11.6bn for Bioverativ

January 22, 2018
Sales and Marketing Sanofi, biotech, bioverativ, drugs, pharma, pharmaceutical

Sanofi interest in making a big acquisition has been clear for the last few years and its struggles to solidify …

News
astrazeneca_sign_sky

AstraZeneca scores double approvals in Japan for asthma and ovarian cancer

January 19, 2018
Medical Communications, Sales and Marketing AstraZeneca, Cancer, Fasenra, Japan, asthma, lynparza, ovarian cancer, pharma

AstraZeneca has unveiled a double dose of approvals awarded to its medicines in Japan: Fasenra (benralizumab) has been given authorisation …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Boehringer, CAR T, CAR-T, Celgene, Kymriah, Merck KGaA, Novartis, Philippines, Sanofi, gilotrif, juno therapeutics, nestle, top ten

It’s Friday, so it’s time to bring you another run-down of the top ten most popular articles with Pharmafile.com’s readers …

News
sandoz

Novartis enters biosimilar agreement with Biocon

January 19, 2018
Medical Communications, Sales and Marketing Biocon, Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical

Novartis’ Sandoz unit had already staked a claim to being one of the leaders in the developing biosimilar market and …

News
pfizer-building-logo1web

Pfizer’s Xalkori sees rejection at the hands of NICE in lung cancer

January 19, 2018
Medical Communications, Sales and Marketing Cancer, NCIE, NSCLC, Pfizer, UK, Xalkori, lung cancer, pharma

UK regulator NICE has announced its decision not to recommend Pfizer’s Xalkori (crizotinib) for use on the NHS in the …

News
gilead-sciences

Gilead aims to claim edge with Pfizer CAR-T combo

January 18, 2018
Medical Communications, Research and Development Gilead, Kite, Yescarta, biotech, drugs, pharma, pharmaceutical

Although those in pharma often dislike any references to drugs competing with each other for market as in a ‘race’, …

News
astrazeneca-sign

AstraZeneca expands drug discovery collaboration with X-Chem

January 18, 2018
Research and Development, Sales and Marketing AstraZeneca, X-Chem, pharma

AstraZeneca and X-Chem are to expand their existing drug discovery collaboration, it has emerged. The partnership marks the third agreement …

News
sunrise-1756274_960_720

Riding the wave: The FDA and real world evidence

January 18, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, real world evidence

Following on from this week’s earlier piece on real world evidence, Jacqueline Corrigan-Curay, Director of CDER’s Office of Medical Policy at the FDA, …

Feature
darzalex

NICE meets Janssen halfway over Darzalex

January 18, 2018
Medical Communications, Sales and Marketing J&J, JJ, Janssen, biotech, darzalex, drugs, pharma, pharmaceutical

NICE rejected Janssen’s Darzalex (Daratumumab) back in March last year, concluding that it wasn’t able to accurately determine the efficacy …

News
pregnancy_credit_needed

Evidence mounts yet again against efficacy of common morning sickness pill

January 18, 2018
Research and Development Diclegis, morning sickness, pharma

Evidence is mounting against the efficacy of the common morning sickness pill pyridoxine-doxylamine  (Diclegis, Diclectin), as new study data reveals …

News
blood-20745_960_720

Research calls for BRCA testing in all women

January 18, 2018
Medical Communications, Research and Development BRCA, biotech, drugs, pharma, pharmaceutical

For women, possessing a mutated BRCA1 or BRCA2 gene significantly increases the chances of developing breast or ovarian cancer; at …

News
cabometyx_tablets_60_mg_40_mg_20_mg

Ipsen ends P3 trial on liver cancer early due to strong data

January 18, 2018
Research and Development Cabometyx, Exelixis, biotech, drugs, ipsen, pharma, pharmaceutical

Ipsen and Exelixis, partners in developing Cabometyx (cabozantinib), have revealed that they have cut short a Phase 3 trial into …

News
novartis_outside_1

Novartis’ CAR T therapy Kymriah scores accelerated approval in both Europe and US

January 17, 2018
Research and Development, Sales and Marketing CAR T, CAR-T, EMA, Europe, FDA, Kymriah, Novartis, US, pharma

Following up last year’s ground-breaking news that CAR T therapy Kymriah had become the first such treatment to be approved …

News
biodegradable_sensor

Fully biodegradable sensor offers safer way to monitor lung and brain conditions

January 17, 2018
Research and Development biodegradable sensor, pharma, university of connecticut

Engineers at the University of Connecticut have developed a biodegradable pressure sensor which is designed to, once ingested, aid in …

News
celgene_1_02

Celgene rumoured to be revving up for Juno buyout

January 17, 2018
Research and Development, Sales and Marketing CAR-T, Celgene, Juno, biotech, drugs, pharma, pharmaceutical

Celgene has already started off the year with a bang, announcing a deal with Impact Biomedicines worth a potential $7 …

News
aaeaaqaaaaaaaadzaaaajda2mmvkoduzltaxndctngywns1iztq3lwm3mtg3mzk0njnkyw

Digital solutions from Veeva’s European Commercial & Medical Summit

January 17, 2018
Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical, veeva

When Peter Gassner, CEO and founder of Veeva, provided the keynote speech at the company’s European Commercial & Medical Summit, …

News
merckwindowweb

MSD’s interim Keytruda combo data spooks Roche and BMS

January 16, 2018
Research and Development MSD, Merck, biotech, drugs, keytruda, pharma, pharmaceutical

When PD-1/L1 treatments first came on the market, there was a race to snaffle as many indications as possible for …

News
filippo_6_for_internal_use_online

GSK Consumer Healthcare announces new Asia Pacific Regional Head

January 16, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline

GlaxoSmithKline’s Consumer Healthcare business has revealed that Filippo Lanzi is to take over as Regional Head of Asia Pacific, overseeing …

Appointment
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026